Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $482,300 - $555,907
4,187 New
4,187 $504,000
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $1.21 Million - $1.47 Million
-10,120 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $2.02 Million - $2.91 Million
-15,738 Reduced 60.86%
10,120 $1.32 Million
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $1.17 Million - $1.37 Million
7,329 Added 39.55%
25,858 $4.59 Million
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $1.42 Million - $1.64 Million
9,480 Added 104.76%
18,529 $3.05 Million
Q4 2020

Feb 16, 2021

BUY
$140.71 - $165.05 $1.27 Million - $1.49 Million
9,049 New
9,049 $1.49 Million
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $4.9 Million - $5.64 Million
-39,040 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $193,677 - $227,290
1,590 Added 4.25%
39,040 $5.58 Million
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $66,085 - $95,041
570 Added 1.55%
37,450 $4.64 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $809,880 - $908,267
-5,030 Reduced 12.0%
36,880 $6.2 Million
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $2.99 Million - $3.75 Million
-20,450 Reduced 32.79%
41,910 $7.22 Million
Q1 2018

May 15, 2018

BUY
$135.59 - $157.16 $2.55 Million - $2.96 Million
18,820 Added 43.22%
62,360 $9.42 Million
Q4 2017

Feb 13, 2018

BUY
$131.06 - $150.39 $2.85 Million - $3.27 Million
21,760 Added 99.91%
43,540 $5.86 Million
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $3.11 Million - $3.39 Million
21,780
21,780 $3.19 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.